Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.43 |
| ▸ | FABP7 | O15540 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3785639 | 1.00 | KMT2A (0.44) | KMT2AFABP5FABP7L3MBTL1PDK2 | |
| SCHEMBL30951907 | 1.00 | KMT2A (0.44) | KMT2AFABP5FABP7L3MBTL1PDK2 | |
| SCHEMBL30564450 | 1.00 | KMT2A (0.44) | KMT2AFABP5FABP7L3MBTL1PDK2 | |
| SCHEMBL693889 | 0.92 | L3MBTL1 (0.48) | KMT2AFABP5FABP7L3MBTL1EPHX2 | |
| SCHEMBL6206152 | 0.91 | PRMT5 (0.46) | KMT2AFABP5FABP7L3MBTL1EPHX2 | |
| SCHEMBL30449879 | 0.86 | KMT2A (0.44) | KMT2AFABP5FABP7L3MBTL1EPHX2 | |
| SCHEMBL3783603 | 0.86 | KMT2A (0.44) | KMT2AFABP5FABP7L3MBTL1EPHX2 | |
| SCHEMBL3780174 | 0.86 | KMT2A (0.44) | KMT2AFABP5FABP7L3MBTL1EPHX2 | |
| SCHEMBL29911437 | 0.86 | KMT2A (0.44) | KMT2AFABP5FABP7L3MBTL1EPHX2 | |
| SCHEMBL800040 | 0.84 | SMN1; SMN2 (0.53) | KMT2AFABP5FABP7L3MBTL1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100174096-A1 | Methods for Production of Optically Active Fluoropyrrolidine Derivatives | IM&T RESEARCH, INC. (US) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174096-A1 | Methods for Production of Optically Active Fluoropyrrolidine Derivatives | QDPR, FDPS, DPYD | KMT2A 4142/4885FABP5 1284/4885FABP7 1101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.